Recombinant Enterococcus faecalis Citrate lyase acyl carrier protein, denoted as citD, is a crucial component of the citrate lyase complex in Enterococcus faecalis. This protein plays a pivotal role in the citrate fermentation pathway, which is essential for the bacterium's survival and pathogenicity in various environments. The citrate lyase complex splits citrate into oxaloacetate and acetate, facilitating anaerobic fermentation processes.
The citD protein is part of the citrate lyase complex, which includes three subunits: citD (acyl carrier protein), citE (citryl-ACP oxaloacetate lyase), and citF (acetyl-ACP:citrate ACP-transferase) . citD acts as a carrier protein, facilitating the transfer of acyl groups during the enzymatic reactions involved in citrate metabolism.
Protein Details | Description |
---|---|
Protein Name | Citrate lyase acyl carrier protein (citD) |
Alternative Name | Citrate lyase gamma chain |
Source | Enterococcus faecalis (strain ATCC 700802 / V583) |
Expression Region | 1-102 amino acids |
Purity | >85% (SDS-PAGE) |
Uniprot No. | Q82YW1 |
Research on citD and the citrate fermentation pathway in Enterococcus faecalis highlights its importance in the bacterium's ability to thrive in diverse environments. The citrate fermentation pathway is crucial for the bacterium's pathogenicity, as it enhances growth in environments such as blood and urine . The presence of the complete citrate pathway in all E. faecalis strains underscores its role in metabolic preservation and persistence across different habitats .
Transcriptional Regulation of the Citrate Gene Cluster of Enterococcus faecalis. PMC2576652.
The Enterococcus faecalis FabT Transcription Factor Regulates Fatty Acid Synthesis. Frontiers in Microbiology.
Transcriptional Regulation of the Citrate Gene Cluster of Enterococcus faecalis. Journal of Bacteriology.
Implications of the expression of Enterococcus faecalis citrate fermentation pathway. PubMed.
Recombinant Enterococcus faecalis Citrate lyase acyl carrier protein (citD). Cusabio.
KEGG: efa:EF3321
STRING: 226185.EF3321
The citrate lyase acyl carrier protein (citD) is a critical subunit of the citrate lyase complex in Enterococcus faecalis. This complex is essential for the initial step of citrate fermentation, where it catalyzes the splitting of citrate into oxaloacetate and acetate. The citD protein functions specifically as the acyl carrier component within this multienzyme complex, which is encoded as part of the oadHDB-citCDEFX-oadA-citMG operon . As an acyl carrier protein, citD likely requires post-translational modification to attach a prosthetic group necessary for its catalytic function in the citrate lyase complex.
The expression of citD is governed by a sophisticated transcriptional regulation system centered around the GntR transcriptional regulator CitO. The citD gene is part of the oadHDB-citCDEFX-oadA-citMG operon, which is specifically activated in the presence of citrate in the growth medium . Transcriptional analysis has revealed that CitO acts as a novel positive regulator that binds to cis-acting sequences O₁ and O₂ in the intergenic region between the divergent citHO and oadHDB-citCDEFX-oadA-citMG operons .
Research approaches to study this regulation include:
Constructing reporter gene fusions to monitor promoter activity
Performing electrophoretic mobility shift assays (EMSAs) to verify CitO binding to the regulatory regions
Creating citO knockout strains to confirm the regulatory relationship
Quantitative RT-PCR to measure transcript levels in response to different conditions
The affinity of CitO for its binding sites increases significantly when citrate is present, allowing for the coordinated induction of both cit promoters .
Successful expression of recombinant citD requires careful optimization of several parameters:
Parameter | Recommended Conditions | Rationale |
---|---|---|
Expression Host | E. coli BL21(DE3) or similar | Lacks lon and ompT proteases; compatible with T7 expression system |
Growth Temperature | 16-25°C | Reduces inclusion body formation for better solubility |
Induction | 0.1-0.5 mM IPTG | Lower concentrations favor proper folding |
Media Supplements | 5-10% glycerol | Stabilizes protein during expression |
Lysis Buffer | pH 7.5-8.0 with 10% glycerol | Maintains stability during purification |
When expressing citD, researchers should be aware that as an acyl carrier protein, it likely requires post-translational phosphopantetheinylation to be fully functional. This modification may need to be engineered into heterologous expression systems by co-expressing the appropriate phosphopantetheinyl transferase.
A methodological approach would include testing multiple strains, optimizing codon usage for the expression host, and validating protein activity through functional assays involving the complete citrate lyase complex .
Working with Enterococcus faecalis presents significant challenges for genetic manipulation that directly impact citD studies:
Physical barriers: E. faecalis possesses a thick cell wall that limits DNA uptake during transformation procedures .
Enzymatic barriers: Multiple restriction modification (RM) systems, including types I, II, and IV, as well as CRISPR-Cas systems, impede the introduction of foreign DNA .
Strain variability: Laboratory strains amenable to transformation (such as JH2-2) are not representative of clinical isolates, limiting translational relevance .
To overcome these barriers, researchers can employ several strategies:
Use DNA isolated from the same E. faecalis strain to avoid restriction
Methylate plasmid DNA prior to transformation to protect against restriction enzymes
Optimize electroporation conditions with higher voltage and shorter pulse duration
Employ temperature-sensitive vectors for genomic integration (such as pGh9 used for citO interruption)
Consider conjugation-based methods for DNA transfer
Utilize the JH2-2 strain for initial studies, as it has been successfully used for genetic manipulations in citrate metabolism research
For targeted modification of citD, a single recombination approach similar to that used for citO interruption could be applied, where an internal fragment of citD is cloned into a thermosensitive vector like pGh9 .
While direct evidence linking citD to virulence is limited in the search results, citrate metabolism likely contributes to E. faecalis adaptation to various ecological niches:
Gastrointestinal tract: Citrate utilization may provide a competitive advantage in the nutrient-limited environment of the human and animal microflora, where E. faecalis is a natural member .
Food environments: Citrate fermentation plays an important role in aroma development during cheese production and other fermented foods, contributing to E. faecalis' beneficial role in food production .
Potential connection to virulence: As a nosocomial pathogen, E. faecalis must adapt to different nutrient conditions during infection. The ability to utilize citrate could potentially contribute to persistence in certain infection sites.
Research methodologies to explore this connection might include:
Comparing citD expression levels between commensal and clinical isolates
Creating citD knockout strains and testing virulence in infection models
Evaluating growth in citrate-containing media that mimics specific host environments
Transcriptomic analysis comparing citD expression under various stress conditions
Understanding the role of citD in adaptation may help explain E. faecalis' ability to transition between commensal and pathogenic lifestyles.
When investigating recombinant citD function, researchers should implement the following critical controls:
Control Type | Purpose | Implementation |
---|---|---|
Negative enzymatic control | Verify specificity of activity | Heat-inactivated citD protein |
Post-translational modification control | Ensure proper protein activation | Comparison of modified vs. unmodified citD |
Substrate specificity control | Confirm catalytic specificity | Test alternative substrates structurally similar to citrate |
Complex formation control | Verify proper assembly | Size-exclusion chromatography or native PAGE |
Activity reconstitution | Confirm functional complementation | Mixing purified citD, citE, and citF subunits |
Additionally, researchers should verify protein identity through mass spectrometry and confirm the presence of expected post-translational modifications. When reconstituting the complete citrate lyase complex, stoichiometric ratios of citD, citE, and citF should be optimized and verified .
Differentiating the specific contributions of citD from other components in the citrate fermentation pathway requires several methodological approaches:
Gene-specific knockouts: Creating individual knockout strains for citD, citE, citF, and other pathway components allows researchers to identify phenotypic differences specific to each gene's function .
Complementation studies: Reintroducing functional copies of each gene (as demonstrated with citO) can confirm gene-specific effects and rule out polar effects on downstream genes .
Biochemical reconstitution: In vitro reconstitution of the citrate lyase complex with purified components, systematically omitting or replacing individual subunits, can reveal their specific contributions.
Protein-protein interaction studies: Techniques such as bacterial two-hybrid assays, co-immunoprecipitation, or surface plasmon resonance can map the interaction network within the complex.
Structural biology approaches: Solving the structure of individual components and the assembled complex can provide mechanistic insights into how each subunit contributes to catalysis.
The citrate fermentation pathway in E. faecalis involves multiple proteins across two operons, making it essential to isolate the specific role of citD through these complementary approaches .
CitD presents a potential target for antimicrobial development based on several characteristics:
Metabolic importance: As part of the citrate lyase complex, citD is involved in a key metabolic pathway that may be essential for E. faecalis survival in certain environments or infection sites .
Unique structure: As an acyl carrier protein with specific post-translational modifications, citD likely contains structural features distinct from host proteins, potentially allowing for selective targeting.
Conserved function: The citrate lyase complex is involved in all known anaerobic bacterial citrate fermentation pathways, suggesting potential broad-spectrum applications .
Research approaches for antimicrobial development could include:
High-throughput screening of compound libraries for inhibitors of citD function
Structure-based drug design targeting the active site or protein-protein interaction surfaces
Peptidomimetic inhibitors that disrupt complex assembly
Prodrugs activated by the citrate metabolism pathway
Given the increasing prevalence of antibiotic resistance in enterococci, novel targets like citD could provide alternative therapeutic strategies focusing on virulence attenuation rather than growth inhibition.
The interconnection between citD-mediated citrate metabolism and other metabolic pathways in E. faecalis represents an important area for future research:
Carbon flux distribution: How does citrate utilization affect central carbon metabolism under different growth conditions? Methodological approaches would include metabolic flux analysis using isotope-labeled substrates.
Regulatory cross-talk: Investigation of how the CitO regulator interacts with other transcriptional networks could reveal integration points between citrate metabolism and other pathways .
Environmental adaptation: Studies examining citD expression and activity across different oxygen levels, pH values, and nutrient compositions would illuminate its role in environmental adaptation.
Metabolic engineering applications: Understanding citD's role in the broader metabolic network could inform strategies for engineering E. faecalis strains with enhanced properties for food or industrial applications.
The citrate metabolism pathway in E. faecalis produces acetate, CO₂, formate, and smaller quantities of lactate, acetoin, and ethanol, suggesting connections to multiple metabolic pathways that could be explored through systems biology approaches .